Vagus nerve wearables — new launch review

Pulsetto FIT X — the next-generation vagus nerve stimulator, reviewed on the mechanism

Pulsetto's September 2026 FIT X relaunch bets on a redesigned bilateral neck electrode and a 'Stress Resilience Score' — reviewed on what transcutaneous VNS can and cannot do

Pulsetto's FIT X, launched September 2026, is the second generation of the Lithuanian company's neck-worn vagus nerve stimulator: a redesigned X-shaped bilateral electrode for more consistent skin contact, paired with an app and a new 'Stress Resilience Score'. The framing has shifted from 'manage stress' to 'Stress Fitness' — train the nervous system the way you train a muscle. That framing is more honest than most of the category, because VNS effects really are dose-and-consistency dependent. The open questions are the same as they were for generation one: cervical transcutaneous stimulation is the least validated of the non-invasive VNS sites, the evidence base is still small and short, and a resilience score is only as good as the HRV maths underneath it.

Pulsetto FIT X — the next-generation vagus nerve stimulator, reviewed on the mechanism

What it claims

  • 'Train your nervous system' through regular vagus nerve stimulation
  • Redesigned X-shaped bilateral electrode for more secure, consistent neck contact
  • Personalised 'Stress Resilience Score' tracking recovery capacity over time
  • Improved recovery, emotional regulation, sleep quality and resilience with consistent use

What the label is not telling you

  • Cervical tVNS is the weakest-evidenced VNS site. The strongest human evidence for non-invasive VNS is auricular — stimulation of the tragus or cymba conchae, where the vagus actually reaches the skin (the auricular branch, mapped by Peuker and Filler 2002). Cervical stimulation targets the nerve bundle in the neck, deeper under muscle and fascia, where dose delivery is far less certain. Pulsetto stimulates the neck. That does not make it useless — it makes the honest claim 'may stimulate' rather than 'stimulates'.
  • The 'Stress Fitness' reframe is genuinely better than the old 'stress relief' pitch. VNS research consistently shows effects build with repeated sessions over weeks, not single uses — the same adaptive pattern as exercise. If the reframe gets users to do 4–8 weeks of consistent sessions before judging, it improves the product's real-world performance.
  • A 'Stress Resilience Score' is HRV in a costume. RMSSD-based HRV is a legitimate, noisy proxy for vagal tone. Any composite score built on it inherits the noise: caffeine, alcohol, illness, menstrual phase and a bad night all move it. Treat the score as a trend line over weeks, never a daily grade.
  • The evidence base is still small, short and mostly not on this device. The encouraging tVNS literature (reduced stress response, improved HRV, some sleep and mood signal) comes largely from research-grade auricular devices and small trials. Consumer cervical devices mostly cite the mechanism, not their own RCTs. That is normal for the category and worth knowing before paying.

Effect on the nervous system

The vagus nerve is the main parasympathetic highway — the wiring that runs the rest-and-digest side of the autonomic seesaw. Stimulating it electrically is a real, studied intervention: implanted VNS is an approved treatment for epilepsy and depression, and transcutaneous versions aim at the same target from outside the skin. The plausible mechanism for a consumer device is afferent vagal signalling nudging brainstem nuclei (nucleus tractus solitarius, then locus coeruleus) toward a more regulated baseline — with repeated sessions, potentially improving vagal tone the way repeated training improves fitness. The keyword is 'potentially'. Where this category earns its keep is as a forcing function: 10 minutes of sitting still while a device hums on your neck is, physiologically, 10 minutes of deliberate downshift, and the ritual itself is parasympathetic training whether or not the current does the heavy lifting.

Who it might suit

People who respond to structure and gadgets — the ones who will actually do a daily 10-minute session because a device tells them to. Anyone who found breathwork hard to stick to but likes measurable routines. Biohackers who understand they are buying a plausible mechanism, not a proven therapy.

Who should skip it

Anyone with an implanted electrical device (pacemaker, cochlear implant), carotid artery disease, or a history of syncope — neck stimulation is not for you without medical sign-off. Anyone expecting a single session to fix chronic stress. And anyone whose real problem is seven hours of sleep and no daylight: the device will not out-stimulate a structural problem.

Bottom line

A reasonable second-generation device with an honest new framing, sitting on a plausible-but-unproven delivery site. Score 6/10: the Stress Fitness model and consistency-first design are the right ideas; the cervical site and thin device-specific evidence keep it in 'use with care'. If you buy it, commit to 8 weeks of daily sessions and judge it on sleep and morning HRV trends, not on how a single session feels. The free version of the same target is slow exhale-led breathing — the hacks library has the protocols, and the Nervous System Journal is where you track whether any of it is actually moving your baseline.